A detailed history of D. E. Shaw & Co., Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 201,264 shares of TMO stock, worth $124 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
201,264
Previous 57,676 248.96%
Holding current value
$124 Million
Previous $33.5 Million 232.02%
% of portfolio
0.11%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $77.8 Million - $86 Million
143,588 Added 248.96%
201,264 $111 Million
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $23.7 Million - $26.9 Million
-44,821 Reduced 43.73%
57,676 $33.5 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $49.5 Million - $61.2 Million
-114,846 Reduced 52.84%
102,497 $54.4 Million
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $26.2 Million - $30.2 Million
-52,575 Reduced 19.48%
217,343 $110 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $115 Million - $133 Million
225,195 Added 503.53%
269,918 $141 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $12.7 Million - $14.3 Million
-23,716 Reduced 34.65%
44,723 $25.8 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $129 Million - $153 Million
-266,942 Reduced 79.59%
68,439 $37.7 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $48.5 Million - $57.8 Million
95,664 Added 39.91%
335,381 $170 Million
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $66.6 Million - $81.4 Million
-132,921 Reduced 35.67%
239,717 $130 Million
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $79.7 Million - $98.1 Million
-152,173 Reduced 29.0%
372,638 $220 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $2.33 Million - $2.73 Million
-4,094 Reduced 0.77%
524,811 $350 Million
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $156 Million - $187 Million
307,070 Added 138.42%
528,905 $302 Million
Q2 2021

Aug 16, 2021

SELL
$441.0 - $508.24 $23.4 Million - $26.9 Million
-52,972 Reduced 19.28%
221,835 $112 Million
Q1 2021

May 17, 2021

BUY
$439.85 - $518.83 $98 Million - $116 Million
222,729 Added 427.68%
274,807 $125 Million
Q4 2020

Feb 16, 2021

BUY
$435.06 - $527.66 $219,270 - $265,940
504 Added 0.98%
52,078 $24.3 Million
Q3 2020

Nov 16, 2020

BUY
$359.77 - $441.52 $2.03 Million - $2.49 Million
5,640 Added 12.28%
51,574 $22.8 Million
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $10.8 Million - $14.2 Million
-39,106 Reduced 45.99%
45,934 $16.6 Million
Q1 2020

May 15, 2020

BUY
$255.3 - $340.05 $5.09 Million - $6.78 Million
19,936 Added 30.62%
85,040 $24.1 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $12.9 Million - $15.5 Million
-47,361 Reduced 42.11%
65,104 $21.2 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $17.9 Million - $20.4 Million
-66,718 Reduced 37.23%
112,465 $32.8 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $14 Million - $16 Million
54,193 Added 43.36%
179,183 $52.6 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $20 Million - $25.9 Million
94,482 Added 309.7%
124,990 $34.2 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $4.9 Million - $5.92 Million
23,488 Added 334.59%
30,508 $6.83 Million
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $1.81 Million - $2.16 Million
-8,827 Reduced 55.7%
7,020 $1.71 Million
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $1.89 Million - $2.04 Million
9,293 Added 141.79%
15,847 $3.28 Million
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $669,833 - $777,885
-3,471 Reduced 34.62%
6,554 $1.35 Million
Q4 2017

Feb 14, 2018

SELL
$182.03 - $200.37 $11.1 Million - $12.3 Million
-61,210 Reduced 85.93%
10,025 $1.9 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $12.2 Million - $13.8 Million
71,235
71,235 $13.5 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $241B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.